Dogs and humans excrete only conjugated bilirubin in the urine, principally the diglucuronide, and unconjugated bilirubin is not excreted by the kidneys (1) . Previous studies concerning the renal excretion of bilirubin have not resolved the issue of whether it is filtered through the glomeruli or is secreted by the tubules (2, 3) .
Bilirubin in the plasma has been reported to be completely bound to proteins (4, 5) regardless of its state of conjugation. Possibly, however, a small portion could be filterable through the glomeruli, although it might be difficult to measure such a portion precisely.' Under such circumstances, conventional renal clearance methods which compare bilirubin clearance (CB) with glomerular filtration rate (GFR) will not define the excretory mechanism.
In the present studies the renal excretion of bilirubin in dogs with obstructive jaundice was therefore examined with other techniques as well. The methods employed were a) the administration of inhibitors of tubular secretory function, b) stop-flow experiments, and c) partial ureteral obstruction. The results were most consistent with excretion of the major portion of bilirubin by glomerular filtration. It is possible that there is also a small contribution from tubular secretion.
Methods
Subjects. The experiments were performed in 40 mongrel female dogs whose weights ranged from 9 to 20 kg. Jaundice was produced by ligation of the com-* Submitted for publication July 30, 1963 ; accepted February 13, 1964 .
A preliminary report of this work was published as an abstract. Clin. Res. 1963, 11, 240. Supported by grants from the U. S. Public Health Service (A-5503) and the American Cancer Society. 1 Such a fraction could be either unbound bilirubin glucuronide or bilirubin glucuronide bound to a filterable carrier molecule. mon bile duct under sterile conditions during intravenous pentobarbital anesthesia. Six to 14 days after operation, when the total plasma bilirubin levels were between 2.4 and 8.0 mg per 100 ml, renal function studies were performed. CB ranged between 1 and 2.5% of the GFR when total plasma bilirubin was used as the denominator in the clearance formula. Plasma bilirubin was fractioned into "15-minute direct-reacting" and total diazotizable pigment in 24 specimens obtained from six dogs between 3 and 19 days after bile duct ligation. In this group the 15-minute direct-reacting fraction averaged 92% (range, 87 to 99%) of the total plasma bilirubin, with no systematic trend during that period. 2 In the present studies, the plasma bilirubin level was stable during the experimental periods on any given day. The only exceptions to this were three of the experiments in which sodium salicylate was administered.
Renal function studies. All experiments were performed under light pentobarbital anesthesia. Bladder urine collections were obtained by indwelling catheter with continuous drainage, and clearance periods were terminated with a distilled water washout. Some of the dogs underwent studies which involved cannulation of first one ureter, and then the other, on separate days.
When an animal was to be used for a second study, the first ureteral cannulation via a flank incision was performed under sterile conditions. At the conclusion of such experiments the plastic catheter was removed, and the ureter ligated. Such animals tolerated the interval between the first and second study well.
Heparinized blood specimens were obtained from an indwelling jugular needle at the mid-point of each clearance period. All drugs were administered intravenously. GFR was estimated by the clearance of either creatinine or inulin at plasma (P) levels of 25 to 30 mg per 100 ml. In addition to conventional clearance experiments two other types of study were undertaken. a) Stop-flow experiments. These were performed according to the method of Malvin, Wilde, and Sullivan (7), using an iv infusion of 10 to 20% mannitol in 0.6%o 2 Seven of these specimens were also fractionated into conjugated and unconjugated bilirubin by the method of Weber and Schalm (6) . The NaCl solution. Glucose was added to the infusion in some experiments. After ureteral urine (U) flow reached 7 to 9 ml per minute, two control free-flow periods were obtained, and the ureteral catheter was then occluded for 6 to 7 minutes. After release of the occlusion serial urine specimens of 1.2 to 1.6 ml were collected,3 and the study was terminated with the collection of two postobstruction free-flow clearance periods. In the first 11 studies creatinine was given in the sustaining infusion, and inulin was given 1 minute before termination of the occlusion to signal the arrival of "new filtrate." In the last four studies inulin was given in the sustaining infusion, and creatinine was given 1 minute before release of the occlusion. Specimens were analyzed for bilirubin, creatinine, inulin, and glucose, and in the last four experiments, for protein. The graphic presentations are given in terms of the ratio of U/PblIlrubin to U/Pcreatinine or U/Pinu11n as suggested by Pitts, Gurd, Kessler, and Hierholzer (8) .
b) Acute partial ureteral obstruction. Animals in which one ureter had been cannulated through a flank incision were given a sustaining infusion of 5% or 6% mannitol in 0.6% NaCl solution. The urine flow usually came into volume equilibrium with the infusion in 60 to 90 minutes. When ureteral urine volume reached 2 to 3 ml per minute, three (or occasionally two) control 10-minute clearance periods were taken, after which the ureteral catheter was elevated 20 to 50 cm above the kidney. After a generous discard period (consisting of at least two estimated dead space volumes), two consecutive clearance periods were taken at this level. In most of the experiments the catheter was then elevated an additional 5 to 20 cm and two more periods were obtained. In some of the early experiments two further urine collections were obtained after the catheter had been returned to its preobstruction level. These periods did not provide more information and were omitted in later studies. GFR was estimated by the creatinine clearance (CCr) in the first 13 experiments, and the inulin clearance (CIn) was used in the last four experiments. Renal plasma flow (RPF) was estimated by the clearance of para-aminohippurate (PAH) at plasma levels of 1.5 to 2.0 mg per 100 ml. 4 Chemical methods. Spectrophotometric determinations were performed in duplicate, except for the urinary bilirubin and Folin estimations in the stop-flow experiments. In those instances, single determinations were dictated by the small sample size. a) Bilirubin. In two of the probenecid studies, urinary bilirubin was determined with a modified Fouchet reaction (9) . In subsequent experiments both plasma and 3 The relatively large specimen volumes were necessary for accurate determination of bilirubin concentration. 4 PAH at these levels increased the urinary excretion of bilirubin by about 10 to 12% (see below Urine specimens from two dogs were studied before common duct ligation was performed. The diazo color reactions were not typical of azobilirubin, but the absorbance in each case gave a concentration value that was equivalent to the excretion of 4 Ag of bilirubin per minute. This was less than 5% of the total urinary diazotizable material excreted by the jaundiced dogs, and hence no correction was applied for this blank. b) Creatinine was determined in urine and acid tungstate filtrates of plasma by an alkaline picrate method (11) . c) Inulin was determined in urine and in trichloroacetic acid filtrates of plasma by the method of Higashi and Peters (12) . In the last four stop-flow experiments, it was measured in an autoanalyzer 5 by an adaptation of the same colorimetric procedure. d) PAH in urine and in cadmium sulfate filtrates of plasma was determined by the method of Smith and coworkers (13) . e) Glucose in urine and in barium hydroxide-zinc sulfate filtrates of plasma was determined by the NelsonSomogyi method (14 dialysis both mitigated against attainment of equilibrium. These conditions were nevertheless chosen in order to minimize loss of dialyzed pigment and to heighten the concentration of pigment in the dialyzate. Plasma specimens were dialyzed in the presence of certain organic anions that had been added to the buffered saline. Other specimens obtained during the clearance experiments, before and after the administration of probenecid or salicylate, were also studied. The absorption spectra of the native dialyzates were measured in a Zeiss spectrophotometer,7 and of the diazotized specimens in a Coleman Senior spectrophotometer, with cuvettes of 5-cm light path.
Results
Diuresis and urinary alkalinization. The effect of diuresis upon urinary bilirubin excretion was assessed specifically in two experiments and observed in many others. The data in Table I indicate the absence of any effect of saline diuresis in those two studies. In other experiments urine volume ranged from control levels of 1 ml per minute up to 8 ml per minute, also without influencing bilirubin excretion.
The effect of urinary alkalinization was examined in three studies in which sodium bicarbonate was infused at rates between 1,200 and 2,700 Imoles per minute, and in three others in which acetazolamide was administered in doses of between 5 and 25 mg per kg. The data in Table II reported here because the absorption spectra of the faint yellow ultrafiltrates did not conform perfectly with those of bilirubin. Dialyzates of plasma, on the other hand, did exhibit the appropriate spectral characteristics. These were a) an absorption maximum of the native dialyzate at between 435 and 445 m~u and b) maximal absorption of the violet azo derivative at 540 to 550 mpt. These features were the same as those of the urinary pigment of the jaundiced dogs and of chemical bilirubin in aqueous alkaline solution. 8 Fasting plasma specimens were dialyzed against phosphate-buffered saline as the control and against buffered saline to which had been added the sodium salt of one of the organic anions in approximately twice the concentration we wished to achieve in the plasma. The equilibrium concentrations of these agents in plasma would presumably be somewhat greater than half the original concentration, depending upon the extent of their binding to plasma proteins. The drug concentrations were high in order to enhance pigment dialyzability to permit determination of the absorption maximum of the azo derivative. The effects of PAH, probenecid, and salicylate on plasma bilirubin dialyzability were each examined in at least three separate experiments using icteric plasma from different dogs. Each of these or- Table I. t Urinary pH was approximated with test paper. 8 The dialyzates derived from both plasma specimens obtained during the probenecid clearance experiment (Table IV) ganic anions regularly evoked increased dialyzability of bilirubin from dog plasma. The data given in Table III derive from a representative series of studies using plasma obtained from one dog 5 days after bile duct ligation, at which time its plasma bilirubin level was 4.4 mg per 100 ml. The salicylate experiment was performed with fresh plasma, and the others with samples of the same plasma that had been stored at -200 C until the day of use.9 Plasma specimens obtained before and after the administration of probenecid (60 mg per kg) and salicylate (120 mg per kg) intravenously to two dogs were also subjected to dialysis against buffered saline. The data given in Tables IV and V show increased pigment dialyzability after the administration of those agents.
Inhibitor experiments. Probenecid administered in a dose of 25 mg per kg, in three experiments, and 60 mg per kg in one experiment, did not cause a decrease in CB or CB/GFR. In the first two studies in which urinary bilirubin was determined by the Fouchet reaction, there was no 9 The dialyzable fraction was stable during such storage for at least 3 months. The variation in the absorbancies of the control dialyzates in Table III was attributable to using different lengths of dialysis casing in different runs, thereby altering the extent of dialysis from one run to another. In any one run all of the dialysis sacs were prepared with scrupulous uniformity. significant change in CB/CC. after the administration of the drug. In the other two studies in which urinary bilirubin was determined by diazotization, CB/GFR increased about 20%. One of those dogs was given a dose of 25 mg per kg. and the other was given 60 mg per kg. Table  IV summarizes the last study. An explanation for the differing responses is not evident, but in no case did this inhibitor cause a decrease in bilirubin excretion. Plasma obtained just before and just after the administration of probenecid in the last experiment was subjected to dialysis. In keeping with the results found in vitro, the data in Table IV show an increase in dialyzable pigment in the postprobenecid plasma. 8 Competitor experiments. The effect of PAH administration was assessed in four studies. In three the plasma level of PAH was varied between 1.0 and 2.5 mg per 100 ml. At these levels there was a 10 to 12% increase in CR and CB/CIn compared with control periods. In the fourth study a dose of 50 mg per kg was given very rapidly. There was a 22%o decrease in CCr which was unattended by any change in urinary bilirubin excretion (UBV) or CB, so that CB/CCr rose 25%. 14 days before the experiment. Urine was collected from the bladder. Plasma bilirubin, 2.4 mg per 100 ml. 5 ml of each plasma specimen was dialyzed against 5 ml of phosphatebuffered saline for 43 hours. Abbreviations as in Table I Start sustaining infusion of 4 mg/ml creatinine in 0.9% NaCl at 4 ml/min -45
Change sustaining infusion to 2 mg/ml creatinine in 0.9% NaCi at 8 ml/min -10 Change sustaining infusion to 4 mg/ml creatinine in 0.9% NaCl at 4 ml/min 13 kg, underwent common bile duct ligation 21 days before the experiment. Urine was collected from the bladder. 5 ml of each plasma specimen was dialyzed against 5 ml of phosphate-buffered saline for 25 hours. PB = plasma bilirubin. Other abbreviations as in Table I . 4 and 5 derive from individual experiments performed using creatinine and inulin, respectively, as indicators of water reabsorption from the tubules. The smooth curves in each figure represent the average for each group of studies. These were obtained by plotting the appropriate values from each experiment and drawing smooth curves through the points. Total nephron urine volume during occlusion was taken as that obtained from release of occlusion, to the specimen in which the glomerular marker concentration reached 50% of its peak value. This total volume (100%) was divided into tenths, and the clearance ratios at the mid-point of each decile were read from the curves, averaged, and plotted.
THE RENAL EXCRETION OF BILIRUBIN IN DOGS WITH OBSTRUCTIVE JAUNDICE
There was an abrupt rise in the bilirubin curve above the free-flow levels in specimens proximal to the one in which the glomerular marker reached 50% of its peak concentration, in eight of the 11 creatinine experiments, and in each of the four inulin experiments. That is, those specimens which contained an increasing proportion of "new filtrate" had a higher concentration of bilirubin than had been present in the free-flow urine. In the inulin experiments this "glomerular-level peak" ranged between 18 and 42% (average, 24%o) above the preobstruction free-flow CB/CIn.
In that group the curve for Folin absorbance/ U/PIn has a similar configuration, with a peak at the same level of the nephron. The far distal peak of Folin-reactive material is similar in location to that described by Aukland in his stopflow studies of urinary protein excretion (17) .
A slight trough in the bilirubin curve is evident in Figures 4 and 5 . It was more prominent in the creatinine experiments, in which it was most pronounced in the proximal tubule area marked by the glucose trough. In the eight of 11 creatinine experiments in which it was found, the trough ranged from 10 to 50%o (average, 26%) below the free-flow CB/CCr. It was barely evident in the inulin experiments. There was a slight distal peak in the bilirubin curve ( Figure  5 ) in four of the creatinine experiments and in one of the inulin experiments, and it was most Post- Curves from above downward refer to bilirubin, creatinine, and glucose, respectively. Pre-and post-refer to the free-flow control periods. The points refer to a single experiment in dog N-1, 13 kg, performed 9 days after common bile duct ligation. Plasma bilirubin, 5.3 mg per 100 ml; priming dose, 2.8 g creatinine intravenously; sustaining infusion, 0.2%o creatinine in 10% mannitol-10% glucose-0.9% NaCl at 10 ml per minute; free-flow Ccr, 38 ml per minute (left kidney) rate of flow, 6 ml per minute; 8' occlusion. The points refer to a single experiment in dog 63-3, 14 kg, performed 10 days after common bile duct ligation. Plasma bilirubin, 3.4 mg per 100 ml; priming dose, 3 .0 g inulin intravenously; sustaining infusion, 0.2% inulin-10% mannitol-0.45% NaCl at 10 ml per minute; freeflow Ci., 35 That feature of the U/Pcr pattern also minimized the glomerular level peak of bilirubin.
Physiological considerations. CB/GFR was not decreased by the administration of PAH, probenecid, or salicylate. Carinamide, 2,4-dinitrophenol, and tolazoline were administered because these substances might compete with a possible bilirubin tubular secretory process, and they were also shown not to decrease CB/GFR (20) . Several of the organic anionic agents actually caused an increase in UBV. Organic anionic compounds have been shown to displace unconjugated bilirubin from plasma protein (21) Partial ureteral obstruction experiments were performed to dissociate GFR and RPF (25) (26) (27) in order to learn whether the CB changed concordantly with one or the other parameter. This technique is less drastic than the stop-flow method, and it has been shown not to interfere with tubular secretion of PAH (26) or phenol red (7) . If bilirubin were secreted by the proximal tubules, changes in its clearance should correspond more closely with changes in RPF at excretory rates less than maximal rate of transport (Tm). At levels well above Tm, changes in CB should correspond better with changes in GFR.
The finding of equivalent changes of CB and GFR therefore suggests that glomerular filtration does play an important role in the urinary excretion of bilirubin in dogs. It does not exclude participation of a tubular secretory process, but is suggests that if one exists, it is of modest magnitude in relation to filtration.
This technique may prove useful in examining the mode of renal excretion of other materials that are either macromolecular or bound to protein. Tubular reabsorption of a substance may preclude the finding of a clear relation to either GFR or RPF.
The nature and precise extent of the binding of bilirubin to plasma proteins must be elucidated before the renal excretory process can be fully characterized. Earlier studies in humans indicated that the circulating bilirubin was completely bound to plasma proteins (4, 5) and largely (28, 29) or wholly (4, 30) to albumin. The renal excretion of albumin is too small to account for the magnitude of the reported CB in either dogs or humans (31, 3) . It might be hypothesized that a bilirubin-protein complex is filtered, bilirubin then being cleaved from protein, leaving the pigment to be excreted in the urine. This concept poses the problem that such a large amount of protein is not believed to be filtered through the glomeruli (31) . It was therefore inferred that bilirubin was secreted by the renal tubules (32) . This hypothesis gained credence after it was found that the urinary pigment was predominantly a glucuronide conjugate of bilirubin (1). Tubular secretion of glucuronide conjugates is recognized (33) , although most of them are phenolic glucuronides, whereas conjugated bilirubin is a carboxyglucuronide (34) .
The results of dialysis studies carried out in this laboratory suggest that a small fraction of 1200 THE RENAL EXCRETION OF BILIRUBIN IN DOGS WITH OBSTRUCTIVE JAUNDICE the total plasma bilirubin in dogs and in humans (35) with obstructive jaundice is dialyzable. The circumstances of the present studies render it difficult to translate the absorbance measurements to values for total dialyzable bilirubin concentration. The values are of about the correct order of magnitude, however, to account for the observed CB/GFR findings. The excretion of bilirubin by a process of glomerular filtration in chickens has also been suggested by Williamson, Robinson, and Owen on the basis of studies using the Sperber technique (36).
Summary
The renal excretion of bilirubin was studied in dogs with obstructive jaundice induced by common bile duct ligation. The administration of conventional inhibitors and competitors of tubular secretory processes did not cause any decrease in urinary bilirubin excretion. Several of the agents, having in common a considerable binding to plasma proteins themselves, caused an increase in urinary bilirubin excretion. This phenomenon was attributed to displacement of conjugated bilirubin from its carrier plasma proteins by these organic anions.
Stop-flow studies showed a peak in the bilirubin curve at the glomerular level, which was interpreted as arising from glomerular filtration of protein-bound bilirubin during ureteral occlusion. A small distal peak may represent a secretory locus of modest capacity, but has not been demonstrated consistently.
When the induction of partial ureteral obstruction caused a greater decrease of glomerular filtration rate than renal plasma flow, bilirubin clearance was found to parallel the former closely and to diverge from the latter. These studies suggest predominance of glomerular filtration over tubular secretion in the renal excretion of bilirulbin.
